SNCA and Parkinson disease: Parkinson’s disease (PD) is recognized as the second most prevalent neurodegenerative disorder, marked by the gradual loss of dopaminergic neurons located in the substantia nigra pars compacta (SNpc) and the formation of Lewy bodies, which primarily contain abnormal alpha-synuclein (α-Syn) aggregates [1,2].